Background Patients with chronic obstructive pulmonary disease (COPD) have increased
cardiovascular risk. Natriuretic peptides (NP) in other populations are useful in identifying …

Abstract Background Natriuretic peptides (NPs) are considered a useful tool for diagnosing
the cardiac or pulmonary origin of acute dyspnea in the emergency department. The aim of …

There are currently no accepted and validated blood tests available for diagnosing acute
exacerbations of chronic obstructive pulmonary disease (AECOPD). In this study, we sought …

Introduction Left ventricular systolic dysfunction (LVSD) and cardiac decompensation often
accompany AECOPD. Differentiation between the two is difficult and mainly relies on clinical …

Background: The prognostic value of amino terminal pro-brain natriuretic peptide levels in
patients with acute exacerbation of chronic obstructive pulmonary disease has not been fully …

Background patients with acute AECOPD show an abrupt worsening of baseline ventricular
function and pulmonary hypertension, using clear predictors or markers for severity in such …

Introduction: COPD and heart failure effecting millions of people in the world where as
combinedly becomes deadlier and affecting the major population of different regions of …

Background: In patients with acute aggravation of chronic obstructive pulmonary disease,
the predictive relevance of amino terminal pro-brain natriuretic peptide levels has not been …

The history of research on the natriuretic peptides can be traced back to 1956 when early
studies using the electron microscope showed that granules similar to those in endocrine …

Background: Among COPD patients, cardiovascular diseases (CVD) are responsible for
approximately 50% of all hospitalizations and 20% of all deaths. BNP has been shown to be …